Skip to main content
. 2020 Dec 1;10(12):4568–4584.

Table 2.

Transgenic platforms for the humanized immune mouse model

Name Transgenic molecules Advantages Limitations Reference
NBSGW c-Kit Without irradiation; development of erythropoiesis and platelet Not reported [56]
NSG-SGM3 SCF, GM-CSF, IL-3 Stable HSCs engraftment; increased monocytes, macrophages and DCs Impaired stem cell function; short-term reconstitution [72]
NOG-EXL GM-CSF, IL-3 Stable HSCs engraftment; increased monocytes, macrophages and DCs Increased anemia [73]
MISTRG GM-CSF, IL-3, M-CSF, TPO, SIRPα Stable HSCs engraftment; increased monocytes, macrophages and DCs; improved NK cells development Increased anemia; shorter lifespan [62]
NOG-dKO β2mnull, IAβnull Decreased GVHD Less T-cell differentiation [37]
NSG-HLA HLA class I and II HLA-restricted B- and T-cell functions; antigen-specific IgG responses Pre-selection of HLA in donor cells [74,75]